by
CNBC
Sep 21, 2015, 11:33a
The major biotech ETF fell to its lows of the day after Democratic presidential hopeful Hillary Clinton said Monday she would take on “price gouging” in the pharmaceutical industry.
A Sunday New York Times article told of a specialty drug that...